Venture Capital Illusions
The rise and fall of Theranos serves as a cautionary tale about the allure of charismatic leadership and the dangers of unchecked venture capital. As the company promised revolutionary blood testing technology, it raised over $1 billion, only to face allegations of deception and fraud. The discussion highlights the stark gender disparity in venture capital funding, revealing how a lack of diversity may have contributed to the blind faith investors placed in Theranos and its founder.In this clip
From this podcast
Freakonomics Radio
Is Venture Capital the Secret Sauce of the American Economy? | Freakonomics Radio | Episode 482
Related Questions